Alterity Therapeutics Ltd
ASX:ATH

Watchlist Manager
Alterity Therapeutics Ltd Logo
Alterity Therapeutics Ltd
ASX:ATH
Watchlist
Price: 0.008 AUD Market Closed
Market Cap: AU$87m

Wall Street
Price Targets

ATH Price Targets Summary
Alterity Therapeutics Ltd

Wall Street analysts forecast ATH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATH is 0.016 AUD with a low forecast of 0.016 AUD and a high forecast of 0.017 AUD.

Lowest
Price Target
0.016 AUD
102% Upside
Average
Price Target
0.016 AUD
104% Upside
Highest
Price Target
0.017 AUD
110% Upside
Alterity Therapeutics Ltd Competitors:
Price Targets
NCSM
NCS Multistage Holdings Inc
33% Upside
AVDL
Avadel Pharmaceuticals PLC
0% Downside
NN
NextNav Inc
41% Upside
STRO
Sutro Biopharma Inc
141% Upside
QXO
SilverSun Technologies Inc
46% Upside
SDGR
Schrodinger Inc
91% Upside

Revenue
Forecast

8% / Year
Past Growth
345% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
8% / Year
Past Growth
345% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 14 years the compound annual growth rate for Alterity Therapeutics Ltd's revenue is 8%. The projected CAGR for the next 3 years is 345%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATH's stock price target?
Price Target
0.016 AUD

According to Wall Street analysts, the average 1-year price target for ATH is 0.016 AUD with a low forecast of 0.016 AUD and a high forecast of 0.017 AUD.

What is Alterity Therapeutics Ltd's Revenue forecast?
Projected CAGR
345%

For the last 14 years the compound annual growth rate for Alterity Therapeutics Ltd's revenue is 8%. The projected CAGR for the next 3 years is 345%.

Back to Top